182 related articles for article (PubMed ID: 23592884)
1. The clinical significance of breast MRI in the management of ductal carcinoma in situ diagnosed on needle biopsy.
Miyashita M; Amano G; Ishida T; Tamaki K; Uchimura F; Ono T; Yajima M; Kuriya Y; Ohuchi N
Jpn J Clin Oncol; 2013 Jun; 43(6):654-63. PubMed ID: 23592884
[TBL] [Abstract][Full Text] [Related]
2. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.
Huo L; Sneige N; Hunt KK; Albarracin CT; Lopez A; Resetkova E
Cancer; 2006 Oct; 107(8):1760-8. PubMed ID: 16977650
[TBL] [Abstract][Full Text] [Related]
3. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
[TBL] [Abstract][Full Text] [Related]
4. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
5. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience.
Orel SG; Rosen M; Mies C; Schnall MD
Radiology; 2006 Jan; 238(1):54-61. PubMed ID: 16304093
[TBL] [Abstract][Full Text] [Related]
6. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
7. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
[TBL] [Abstract][Full Text] [Related]
8. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
9. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
Renshaw AA; Derhagopian RP; Martinez P; Gould EW
Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
[TBL] [Abstract][Full Text] [Related]
10. Ductal enhancement on MR imaging of the breast.
Liberman L; Morris EA; Dershaw DD; Abramson AF; Tan LK
AJR Am J Roentgenol; 2003 Aug; 181(2):519-25. PubMed ID: 12876038
[TBL] [Abstract][Full Text] [Related]
11. Nipple aspirate fluid cytology in breast carcinoma.
Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
[TBL] [Abstract][Full Text] [Related]
12. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
Ringberg A; Andersson I; Aspegren K; Linell F
Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
[TBL] [Abstract][Full Text] [Related]
13. [In situ ductal carcinoma of the breast: a diagnostic challenge].
Fuchsjäger MH; Helbich TH
Wien Med Wochenschr Suppl; 2002; (113):69-73. PubMed ID: 12621847
[TBL] [Abstract][Full Text] [Related]
14. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
15. MRI accurately depicts underlying DCIS in a patient with Paget's disease of the breast without palpable mass and mammography findings.
Amano G; Yajima M; Moroboshi Y; Kuriya Y; Ohuchi N
Jpn J Clin Oncol; 2005 Mar; 35(3):149-53. PubMed ID: 15741305
[TBL] [Abstract][Full Text] [Related]
16. Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size.
Liberman L; Mason G; Morris EA; Dershaw DD
AJR Am J Roentgenol; 2006 Feb; 186(2):426-30. PubMed ID: 16423948
[TBL] [Abstract][Full Text] [Related]
17. Breast lesions detected on MR imaging: features and positive predictive value.
Liberman L; Morris EA; Lee MJ; Kaplan JB; LaTrenta LR; Menell JH; Abramson AF; Dashnaw SM; Ballon DJ; Dershaw DD
AJR Am J Roentgenol; 2002 Jul; 179(1):171-8. PubMed ID: 12076929
[TBL] [Abstract][Full Text] [Related]
18. Breast magnetic resonance image screening and ductal lavage in women at high genetic risk for breast carcinoma.
Hartman AR; Daniel BL; Kurian AW; Mills MA; Nowels KW; Dirbas FM; Kingham KE; Chun NM; Herfkens RJ; Ford JM; Plevritis SK
Cancer; 2004 Feb; 100(3):479-89. PubMed ID: 14745863
[TBL] [Abstract][Full Text] [Related]
19. Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.
Mackinnon WB; Barry PA; Malycha PL; Gillett DJ; Russell P; Lean CL; Doran ST; Barraclough BH; Bilous M; Mountford CE
Radiology; 1997 Sep; 204(3):661-6. PubMed ID: 9280241
[TBL] [Abstract][Full Text] [Related]
20. MR imaging-guided breast localization system with medial or lateral access.
Causer PA; Piron CA; Jong RA; Curpen BN; Luginbuhl CA; Glazier JE; Warner E; Hill K; Muldoon J; Taylor G; Wong JW; Plewes DB
Radiology; 2006 Aug; 240(2):369-79. PubMed ID: 16775219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]